Medplus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more
Medplus Health Services Limited - Asset Resilience Ratio
Medplus Health Services Limited (MEDPLUS) has an Asset Resilience Ratio of 8.18% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Medplus Health Services Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Medplus Health Services Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 0% |
| Short-term Investments | ₹2.92 Billion | 8.18% |
| Total Liquid Assets | ₹2.92 Billion | 8.18% |
Asset Resilience Insights
- Limited Liquidity: Medplus Health Services Limited maintains only 8.18% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Medplus Health Services Limited Industry Peers by Asset Resilience Ratio
Compare Medplus Health Services Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462 |
Pharmaceutical Retailers | 0.00% |
|
Yunnan Hongxiang Yixintang
SHE:002727 |
Pharmaceutical Retailers | 4.83% |
|
Luyan Pharma Co Ltd
SHE:002788 |
Pharmaceutical Retailers | 0.00% |
|
Ji Yao Holding Group Co Ltd
SHE:300108 |
Pharmaceutical Retailers | -0.02% |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937 |
Pharmaceutical Retailers | 0.06% |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017 |
Pharmaceutical Retailers | 0.41% |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126 |
Pharmaceutical Retailers | 2.54% |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408 |
Pharmaceutical Retailers | 0.94% |
Annual Asset Resilience Ratio for Medplus Health Services Limited (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Medplus Health Services Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 10.53% | ₹3.54 Billion | ₹33.60 Billion | +8.07pp |
| 2024-03-31 | 2.46% | ₹738.26 Million | ₹30.05 Billion | +0.30pp |
| 2023-03-31 | 2.16% | ₹602.99 Million | ₹27.97 Billion | -22.37pp |
| 2022-03-31 | 24.52% | ₹6.36 Billion | ₹25.94 Billion | +21.82pp |
| 2021-03-31 | 2.70% | ₹423.16 Million | ₹15.66 Billion | +0.70pp |
| 2020-03-31 | 2.00% | ₹270.30 Million | ₹13.49 Billion | -0.59pp |
| 2019-03-31 | 2.59% | ₹248.24 Million | ₹9.59 Billion | -- |